MBIB News

Jay Keasling, Associate Laboratory Director for Biosciences, has announced that Paul Adams has accepted the position of Division Director for the Molecular Biophysics & Integrated Bioimaging (MBIB) Division. Adams served as the MBIB Interim Division Director since the Biosciences Area re-organization took effect this past October 1 and has been instrumental in developing a strategic plan and leading the effort to launch the Division.

The annual flu epidemics caused by influenza viruses, especially the influenza A virus, affect about 10–20% of the world’s population each season. This highly contagious illness can trigger serious complications and lead at times to death. A team of scientists led by Bill DeGrado from UC San Francisco have been studying the M2 proton channel from the influenza A virus, which is one of nature’s smallest proton-selective channels and a drug target for this virus. Protein crystallography performed at the Advanced Light Source (ALS) Beamline 8.3.1 helped scientists understand the M2 proton-channel structure and function, and will aid the design of better anti-influenza medications. Read the ALS Science Brief.

The projects of eleven Biosciences Area scientists and engineers received funding through the FY2016 Laboratory Directed Research and Development (LDRD) program. These projects cover a broad range of topics, including energy science technology applications, novel computing technologies, and mechanistic understanding of multi-scale interactions among molecules, microbes, plants, metazoans, the abiotic environment, and their feedbacks. Together, these efforts account for nearly 14% of the $25.3 million allocated. Lab-wide, 84 proposals were selected from a field of 179.

New research shows for the first time that PET scans can track the progressive stages of Alzheimer’s disease in cognitively normal adults, a key advance in the early diagnosis and staging of the neurodegenerative disorder. William Jagust, senior faculty scientist in the Molecular Biophysics & Integrated Bioimaging Division, is the study’s principal investigator. A video abstract of the findings, published March 2 in the journal Neuron, can be found here. Read more at UC Berkeley News.

Faculty biochemist Jennifer Doudna recently sat down with Maria Sterrett, a Genetics Society of America (GSA) member, for the Genes to Genomes blog series, “Behind the Podium.” The UC Berkeley professor and HHMI investigator is now famous for her contribution to the development of the CRISPR/Cas9 system for genome editing and will be one of the keynote speakers at The Allied Genetics Conference (TAGC), set to take place in Orlando this July. In the interview, Doudna stressed the pivotal role played in the scientific community by societies like GSA, saying how important it is “to foster a great community of scientists to exchange ideas.” She also observed that societies encourage younger scientists to get involved in the field and introduce them to the cutting edge advances of their field. Read her interview in Genes to Genomes.